How you walk may matter just as much as how much you walk. A large UK study tracking more than 33,000 low-activity adults found that people who grouped their daily steps into longer, uninterrupted ...

The sixth and final day of the European Short Course Championships in Lublin, Poland will be packed with action. There are 13 finals on the schedule, starting with the women’s and men’s 50 backstroke ...

With short-form video now dominant on social media, researchers are racing to understand how the highly engaging, algorithm-driven format may be reshaping the brain. From TikTok to Instagram Reels and ...

Michael Burry tore into Tesla’s sky-high valuation, blasting the electric-vehicle giant as “ridiculously overvalued” in a fresh broadside that marked his most pointed attack on the company in years.

Every time Theron publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Michael Burry famously predicted the mortgage crisis that struck in 2007 and 2008. Burry has been known to bet against themes in the stock market, and this time, his eye is on artificial intelligence.

Earlier this month, news emerged that Michael Burry, who famously shorted the US housing market before its collapse in 2008, had placed bets worth over $1 billion against the share prices of AI ...

College enrollment continued to grow this fall, increasing by 2 percent compared to fall 2024, according to preliminary fall data released by the National Student Clearinghouse Research Center. The ...

Symbotic (SYM) trades at a $41B valuation with short interest above 33% of float despite recent 15% pullback from highs. Kohl’s (KSS) stock surged 156% over six months and beat earnings while trading ...

ESPN broadcasters Chris Fowler and Kirk Herbstreit poked fun at Oklahoma Sooners kicker Tate Sandell’s shorts during the team’s win against the Tennessee Volunteers. Sandell came into the game to ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Theron Mohamed Every time Theron publishes a story, you’ll get an alert straight to your inbox!

Fueling Viking Therapeutics upside, analysts at Canaccord initiated coverage of the obesity treatment stock with a buy rating, and a price target of $106 a share With a short interest of 25%, Lemonade ...